Therapeutic applications of heat shock proteins.
Edgington
S M
SM
D000818:Animals; D001709:Biotechnology; D002561:Cerebrovascular Disorders / Q000628:therapy; D006360:Heat-Shock Proteins / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents; D009203:Myocardial Infarction / Q000628:therapy; D009369:Neoplasms / Q000628:therapy; D013678:Technology, Pharmaceutical; D014612:Vaccines
D006360:Heat-Shock Proteins; D007166:Immunosuppressive Agents; D014612:Vaccines